MADISON, Wis. (WFRV) – Officials with the US Food and Drug Administration say they have cleared the first-ever blood test that will help in diagnosing cases of Alzheimer’s disease.
Those at UW Health state that this could not have happened without their help, as the work being done at the UW schools of Medicine and Public Health in Madison has been at the forefront of biomarker research.
Brown County courts request aid to address felony case backlog
This kind of research allows those already with cognitive impairment to get a blood test as a way to test for Alzheimer’s instead of needing a PET scan of the brain or a spinal tap.
We have been at the forefront of biosomething research, those are tasks looking at the protein of Alzheimer’s disease, and we’ve been doing this for years. And that’s because our research participants have been willing to do lumbar punctures for the past two decades. And we’ve had the technology to really look for these proteins
Nate Chin, UW Health Alzheimer’s Disease Research Center Medical Director
Chin adds that UW Health is looking to make these blood tests available for cognitively healthy people as well, before eventually pairing it with future preventive Alzheimer’s treatments.
No other information is available at this time.
